VP, Business Development and Strategic Partnerships
A proven leader with a history of bringing clinical diagnostics to market, Mr. Walther comes to Epic Sciences after serving as the Global Head of Genomics Business Development at Q2 Solutions and the Vice President of Business Development and Strategic Partnerships at HTG Molecular. His expertise ranges from advancing molecular technologies and diagnostics by collaborating with large global pharmaceutical and molecular diagnostic companies to clinical labs and biotech settings. His experience spans all phases of drug development as well as bringing to market a number of globally approved solutions to fulfill pharmaceutical development and patient care.
Mr. Walther earned an MBA from University of Colorado at Boulder and Biomedical and Political Science degrees from Colorado State University.